Robert Hutchman, MD
Neurology · Barstow, CANPI 1932118262
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $544 of the $635 with a category attached, or 85.6%. It is spread thinly across 11 manufacturers, the largest accounting for just 23.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $429 and has fallen 83.4% since, to $71 in 2022. That places this record below the midpoint for neurology clinicians in CA, where the typical reported total is $885.
Across 31 payments — averaging $20.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$150
- Acorda Therapeutics, Inc$92
- Abbott$71
- AbbVie$68
- Sanofi$67
- Amneal Pharmaceuticals LLC$52
- plus $136 from 5 others
Across 27 payments — averaging $5197.68 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Amneal Pharmaceuticals LLC$84K
- SK Life Science, Inc.$24K
- Eli Lilly$22K
- Acadia Pharmaceuticals Inc$11K
What the payments were for
- Speaking & faculty fees$9214%
- Food & beverage$54486%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $150 |
| Acorda Therapeutics, Inc | 4 | $92 |
| Abbott | 1 | $71 |
| AbbVie(2 entities) | 4 | $68 |
| Sanofi | 3 | $67 |
| Amneal Pharmaceuticals LLC | 2 | $52 |
| Acadia Pharmaceuticals Inc | 2 | $45 |
| Vertical Pharmaceuticals, LLC | 2 | $29 |
| Amgen | 1 | $27 |
| Lundbeck LLC | 1 | $20 |
| Adamas Pharmaceuticals, Inc. | 1 | $15 |
How this compares
$635 in reported general payments places this provider in the 45th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology in Barstow
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.